Is MTEM or JEPQ a better dividend investment in 2026?

MTEM currently yields 2000000.06% with a 5% 5-year dividend growth rate. JEPQ yields 11.10% with 5% growth. The better choice depends on your goal: MTEM offers higher current income.

What is the dividend yield difference between MTEM and JEPQ?

MTEM has a forward dividend yield of 2000000.06% ($2.00/share annually). JEPQ yields 11.10% ($6.16/share annually). The yield gap is 1999988.96 percentage points.

Home › Compare › MTEM vs JEPQ

MTEM vs JEPQ: Dividend Comparison 2026

MTEM yields 2000000.06% · JEPQ yields 11.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MTEM wins by $4.8792278646347776e+39M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MTEM

● Live price

2000000.06%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.8792278646347776e+39M

Annual income

$4,878,748,002,861,388,000,000,000,000,000,000,000,000,000,000.00

Full MTEM calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.10%

Share price

$55.52

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.8K

Annual income

$2,152.59

Full JEPQ calculator →

Portfolio growth — MTEM vs JEPQ

📍 MTEM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MTEM	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MTEM + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MTEM pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MTEM

Annual income on $10K today (after 15% tax)

$170,000,005.10/yr

After 10yr DRIP, annual income (after tax)

$4,146,935,802,432,179,400,000,000,000,000,000,000,000,000,000.00/yr

JEPQ

Annual income on $10K today (after 15% tax)

$943.83/yr

After 10yr DRIP, annual income (after tax)

$1,829.70/yr

At 15% tax rate, MTEM beats the other by $4,146,935,802,432,179,400,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MTEM + JEPQ for your $10,000?

MTEM: 50%JEPQ: 50%

100% JEPQ50/50100% MTEM

Portfolio after 10yr

$2.4396139323173888e+39M

Annual income

$2,439,374,001,430,694,000,000,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.99%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MTEM right now

MTEM

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Altman Z

-24.9

Piotroski

2/9

JEPQ

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MTEM buys

JEPQ buys

No recent congressional trades found for MTEM or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMTEMJEPQ

Forward yield	2000000.06% ✓	11.10%
Annual dividend / share	$2.00	$6.16 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$4.8792278646347776e+39M	$44.8K ✓
Annual income after 10y	$4,878,748,002,861,388,000,000,000,000,000,000,000,000,000,000.00 ✓	$2,152.59
Total dividends collected	$4.8791964691115763e+39M	$16.3K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: MTEM vs JEPQ ($10,000, DRIP)

Year	MTEM Portfolio	MTEM Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$200,010,706	$200,000,006.00	$11,930	$1,110.39	+$200.00M → MTEM
2	$3,738,731,992,770	$3,738,517,981,314.42	$14,133	$1,224.34	+$3738731.98M → MTEM
3	$65,315,068,744,949,500	$65,311,068,301,717,240.00	$16,632	$1,340.46	+$65315068744.93M → MTEM
4	$1,066,400,958,023,135,400,000	$1,066,331,070,899,578,300,000.00	$19,454	$1,457.97	+$1066400958023135.38M → MTEM
5	$16,272,185,237,131,282,000,000,000	$16,271,044,188,106,197,000,000,000.00	$22,626	$1,576.08	+$16272185237131282432.00M → MTEM
6	$232,054,281,880,765,440,000,000,000,000	$232,036,870,642,561,700,000,000,000,000.00	$26,175	$1,694.09	+$2.3205428188076545e+23M → MTEM
7	$3,092,799,715,549,616,000,000,000,000,000,000	$3,092,551,417,468,003,600,000,000,000,000,000.00	$30,133	$1,811.32	+$3.0927997155496157e+27M → MTEM
8	$38,524,114,942,504,994,000,000,000,000,000,000,000	$38,520,805,646,809,356,000,000,000,000,000,000,000.00	$34,531	$1,927.17	+$3.8524114942504996e+31M → MTEM
9	$448,468,947,092,778,960,000,000,000,000,000,000,000,000	$448,427,726,289,790,500,000,000,000,000,000,000,000,000.00	$39,403	$2,041.08	+$4.4846894709277894e+35M → MTEM
10	$4,879,227,864,634,777,500,000,000,000,000,000,000,000,000,000	$4,878,748,002,861,388,000,000,000,000,000,000,000,000,000,000.00	$44,787	$2,152.59	+$4.8792278646347776e+39M → MTEM

MTEM vs JEPQ: Complete Analysis 2026

MTEM — Stock

Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT-5111, an ETB candidate that is in Phase I clinical trial for the treatment of HER2-positive cancers; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory myeloma patients; and MT-6402 in that is in Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients. Its pipeline of ETBs in development for other targets, including CTLA-4, TIGIT, TROP2, BCMA, SLAMF-7, and CD45. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.

Full MTEM Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this MTEM vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MTEM vs SCHD MTEM vs JEPI MTEM vs O MTEM vs KO MTEM vs MAIN MTEM vs XYLD MTEM vs QYLD MTEM vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.